Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Yin, Lian Hu ^a,b   Shen, Hui ^a   Diaz Ruiz, Oscar ^a   Bäckman, Cristina M ^a   Bae, Eunkyung ^a   Yu, Seong Jin ^a   Wang, Yun ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; METHAMPHETAMINE; OXIDOPAMINE; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; LOW DRUG DOSE; MALE; MEDIAL FOREBRAIN BUNDLE; NERVE DEGENERATION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; RAT;

ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FEMALE; FUNCTIONAL LATERALITY; IN SITU NICK-END LABELING; MALE; MESENCEPHALON; MOTOR ACTIVITY; NEURODEGENERATIVE DISEASES; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; POTASSIUM CHLORIDE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; SUBSTANTIA NIGRA; TRETINOIN; TYROSINE 3-MONOOXYGENASE;

EID: 84866973960     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-120     Document Type: Article

References (44)

1. Mic FA, Molotkov A, Benbrook DM, Duester G. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc Natl Acad Sci USA 2003, 100:7135-7140. 10.1073/pnas.1231422100, 165842, 12782789.
2. Horton C, Maden M. Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo. Dev Dyn 1995, 202:312-323. 10.1002/aja.1002020310, 7780180.
3. Ulven SM, Gundersen TE, Sakhi AK, Glover JC, Blomhoff R. Quantitative axial profiles of retinoic acid in the embryonic mouse spinal cord: 9-cis retinoic acid only detected after all-trans-retinoic acid levels are super-elevated experimentally. Dev Dyn 2001, 222:341-353. 10.1002/dvdy.1184, 11747070.
4. Werner EA, Deluca HF. Metabolism of a physiological amount of all-trans-retinol in the vitamin A-deficient rat. Arch Biochem Biophys 2001, 393:262-270. 10.1006/abbi.2001.2495, 11556813.
5. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 1992, 355:359-361. 10.1038/355359a0, 1309942.
6. Allenby G, Janocha R, Kazmer S, Speck J, Grippo JF, Levin AA. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid. J Biol Chem 1994, 269:16689-16695.
7. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990, 345:224-229. 10.1038/345224a0, 2159111.
8. Kitamura M, Ishikawa Y, Moreno-Manzano V, Xu Q, Konta T, Lucio-Cazana J, et al. Intervention by retinoic acid in oxidative stress-induced apoptosis. Nephrol Dial Transplant 2002, 17(Suppl 9):84-87.
9. Boniece IR, Wagner JA. NGF protects PC12 cells against ischemia by a mechanism that requires the N-kinase. J Neurosci Res 1995, 40:1-9. 10.1002/jnr.490400102, 7714916.
10. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290:2140-2144. 10.1126/science.290.5499.2140, 11118147.
11. Glozman S, Green P, Yavin E. Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress. J Neurochem 1998, 70:2484-2491.
12. Umemura K, Toshima Y, Asai F, Nakashima M. Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. Thromb Res 1995, 78:379-387. 10.1016/0049-3848(95)00071-X, 7660354.
13. Harvey BK, Shen H, Chen GJ, Yoshida Y, Wang Y. Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci Lett 2004, 369:138-141. 10.1016/j.neulet.2004.07.086, 15450683.
14. Shen H, Luo Y, Kuo CC, Deng X, Chang CF, Harvey BK, et al. 9-Cis-Retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein. J Neurosci Res 2009, 87:545-555. 10.1002/jnr.21865, 2628966, 18803283.
15. Cheung YT, Lau WK, Yu MS, Lai CS, Yeung SC, So KF, et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. NeuroToxicology 2009, 30:127-135. 10.1016/j.neuro.2008.11.001, 19056420.
16. Tieu K, Zuo DM, Yu PH. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res 1999, 58:426-435. 10.1002/(SICI)1097-4547(19991101)58:3<426::AID-JNR8>3.0.CO;2-F, 10518116.
17. Katsuki H, Kurimoto E, Takemori S, Kurauchi Y, Hisatsune A, Isohama Y, et al. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling. J Neurochem 2009, 110:707-718. 10.1111/j.1471-4159.2009.06171.x, 19457078.
18. Ulusoy GK, Celik T, Kayir H, Gursoy M, Isik AT, Uzbay TI. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease. Brain Res Bull 2011, 85:380-384. 10.1016/j.brainresbull.2011.05.001, 21600965.
19. Lin SZ, Hoffer BJ, Kaplan P, Wang Y. Osteogenic protein-1 protects against cerebral infarction induced by MCA-ligation in adult rats. Stroke 1999, 30:126-133. 10.1161/01.STR.30.1.126, 9880400.
20. Wang Y, Lin SZ, Chiou AL, Williams LR, Hoffer BJ. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci 1997, 17:4341-4348.
21. Harvey BK, Mark A, Chou J, Chen GJ, Hoffer BJ, Wang Y. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res 2004, 1022:88-95. 10.1016/j.brainres.2004.06.072, 15353217.
22. Chou J, Luo Y, Kuo CC, Powers K, Shen H, Harvey BK, et al. Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience 2008, 151:92-103. 10.1016/j.neuroscience.2007.10.044, 18082966.
23. Chou J, Harvey BK, Ebendal T, Hoffer BJ, Wang Y. Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice. Acta Neurochir Suppl 2008, 101:93-98. 10.1007/978-3-211-78205-7_16, 2572854, 18642641.
24. Sabeti J, Gerhardt GA, Zahniser NR. Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats. J Pharmacol Exp Ther 2002, 302:1201-1211. 10.1124/jpet.102.035816, 12183681.
25. Sabeti J, Adams CE, Burmeister J, Gerhardt GA, Zahniser NR. Kinetic analysis of striatal clearance of exogenous dopamine recorded by chronoamperometry in freely-moving rats. J Neurosci Methods 2002, 121:41-52. 10.1016/S0165-0270(02)00229-7, 12393160.
26. Wang Y, Chang CF, Morales M, Chiang YH, Harvey BK, Su TP, et al. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci 2003, 23:7958-7965.
27. Yu SJ, Airavaara M, Shen H, Chou J, Harvey BK, Wang Y. Suppression of endogenous PPARγ increases vulnerability to methamphetamine -induced injury in mouse nigrostriatal dopaminergic pathway. Psychopharmacology (Berl) 2012, 221:479-492.
28. Cass WA, Manning MW. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J Neurosci 1999, 19:7653-7660.
29. Ahlemeyer B, Bauerbach E, Plath M, Steuber M, Heers C, Tegtmeier F, et al. Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med 2001, 30:1067-1077. 10.1016/S0891-5849(01)00495-6, 11369496.
30. Ahlemeyer B, Huhne R, Krieglstein J. Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression. J Neurosci Res 2000, 60:767-778. 10.1002/1097-4547(20000615)60:6<767::AID-JNR9>3.0.CO;2-6, 10861789.
31. Hudson JL, van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 1993, 626:167-174. 10.1016/0006-8993(93)90576-9, 8281427.
32. Hoffman AF, Lupica CR, Gerhardt GA. Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices. J Pharmacol Exp Ther 1998, 287:487-496.
33. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455. 10.1016/0022-510X(73)90175-5, 4272516.
34. Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 2003, 26:215-221. 10.1016/S0166-2236(03)00038-9, 12689773.
35. Chang CF, Morales M, Chou J, Chen HL, Hoffer BJ, Wang Y. Bone morphogenetic proteins are involved in fetal kidney tissue transplantation -induced neuroprotection in stroke rats. Neuropharmacology 2002, 43:418-426. 10.1016/S0028-3908(02)00092-8, 12243771.
36. Wang Y, Chang CF, Morales M, Chou J, Chen HL, Chiang YH, et al. Bone morphorgenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke 2001, 32:2170-2178. 10.1161/hs0901.095650, 11546913.
37. Shinozaki Y, Sato Y, Koizumi S, Ohno Y, Nagao T, Inoue K. Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase. Neuroscience 2007, 147:153-163. 10.1016/j.neuroscience.2007.04.032, 17521827.
38. Goldstein JT, Dobrzyn A, Clagett-Dame M, Pike JW, DeLuca HF. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch Biochem Biophys 2003, 420:185-193. 10.1016/j.abb.2003.09.034, 14622989.
39. Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 2011, 31:321-351. 10.1146/annurev.nutr.012809.104635, 3406932, 21756134.
40. Calandria JM, Mukherjee PK, de Rivero Vaccari JC, Zhu M, Petasis NA, Bazan NG. Ataxin-1 poly-Q-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1. J Biol Chem 2012, 287:23726-23739. 10.1074/jbc.M111.287078, 3390647, 22511762.
41. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992, 68:397-406. 10.1016/0092-8674(92)90479-V, 1310260.
42. Liu DM, Lin SZ, Wang SD, Wu MI, Wang Y. Xenografting human T2 sympathetic ganglion from hyperhidrotic patients partially restores catecholaminergic functions in hemi-Parkinsonian athymic rats. Cell Transplant 1999, 8:563-591.
43. Luo Y, Hoffer BJ, Wang Y. Rotation, drug-induced. The encyclopedia of movement disorders (MOVE) 2010, e15193. Academic Press, London, England, Kompoliti K, Verhagen L, 1.
44. van den Berg MP, Romeijn SG, Verhoef JC, Merkus FW. Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity. J Neurosci Methods 2002, 116:99-107. 10.1016/S0165-0270(02)00033-X, 12007987.